Literature DB >> 20682533

Sleep and hypertension.

David A Calhoun1, Susan M Harding.   

Abstract

Ambulatory BP studies indicate that even small increases in BP, particularly nighttime BP levels, are associated with significant increases in cardiovascular morbidity and mortality. Accordingly, sleep-related diseases that induce increases in BP would be anticipated to substantially affect cardiovascular risk. Both sleep deprivation and insomnia have been linked to increases in incidence and prevalence of hypertension. Likewise, sleep disruption attributable to restless legs syndrome increases the likelihood of having hypertension. Observational studies demonstrate a strong correlation between the severity of obstructive sleep apnea (OSA) and the risk and severity of hypertension, whereas prospective studies of patients with OSA demonstrate a positive relationship between OSA and risk of incident hypertension. Intervention trials with continuous positive airway pressure (CPAP) indicate a modest, but inconsistent effect on BP in patients with severe OSA and a greater likelihood of benefit in patients with most CPAP adherence. Additional prospective studies are needed to reconcile observational studies suggesting that OSA is a strong risk factor for hypertension with the modest antihypertensive effects of CPAP observed in intervention studies.

Entities:  

Mesh:

Year:  2010        PMID: 20682533      PMCID: PMC2913764          DOI: 10.1378/chest.09-2954

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  68 in total

1.  Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives.

Authors:  K Kario; T G Pickering; T Matsuo; S Hoshide; J E Schwartz; K Shimada
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Relationship between self-reported sleep duration and changes in circadian blood pressure.

Authors:  Oded Friedman; Yajur Shukla; Alexander G Logan
Journal:  Am J Hypertens       Date:  2009-09-10       Impact factor: 2.689

3.  Is obstructive sleep apnea a risk factor for hypertension?--differences between the Wisconsin Sleep Cohort and the Sleep Heart Health Study.

Authors:  Paul E Peppard
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

4.  Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms.

Authors:  J Ulfberg; B Nyström; N Carter; C Edling
Journal:  Mov Disord       Date:  2001-11       Impact factor: 10.338

5.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

6.  Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex.

Authors:  A G Logan; R Tkacova; S M Perlikowski; R S Leung; A Tisler; J S Floras; T D Bradley
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

7.  Prevalence of restless legs syndrome and periodic limb movement disorder in the general population.

Authors:  Maurice M Ohayon; Thomas Roth
Journal:  J Psychosom Res       Date:  2002-07       Impact factor: 3.006

8.  Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.

Authors:  Eamon Dolan; Alice V Stanton; Simon Thom; Mark Caulfield; Neil Atkins; Gordon McInnes; David Collier; Patrick Dicker; Eoin O'Brien
Journal:  J Hypertens       Date:  2009-04       Impact factor: 4.844

9.  Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Susan M Harding
Journal:  Chest       Date:  2004-01       Impact factor: 9.410

10.  Nighttime blood pressure in normotensive subjects with chronic insomnia: implications for cardiovascular risk.

Authors:  Paola A Lanfranchi; Marie-Hélène Pennestri; Lorraine Fradette; Marie Dumont; Charles M Morin; Jacques Montplaisir
Journal:  Sleep       Date:  2009-06       Impact factor: 5.849

View more
  73 in total

1.  Effect of chronic continual- and intermittent hypoxia-induced systemic inflammation on the cardiovascular system in rats.

Authors:  Xiao-Mei Xu; Dan Yao; Xue-Ding Cai; Cheng Ding; Qian-Ding Lin; Liang-Xing Wang; Xiao-Ying Huang
Journal:  Sleep Breath       Date:  2014-11-14       Impact factor: 2.816

2.  Sleep epidemiology--a rapidly growing field.

Authors:  Jane E Ferrie; Meena Kumari; Paula Salo; Archana Singh-Manoux; Mika Kivimäki
Journal:  Int J Epidemiol       Date:  2011-12       Impact factor: 7.196

Review 3.  Resistant hypertension and sleep apnea: pathophysiologic insights and strategic management.

Authors:  Stephen K Williams; Joseph Ravenell; Girardin Jean-Louis; Ferdinand Zizi; James A Underberg; Samy I McFarlane; Gbenga Ogedegbe
Journal:  Curr Diab Rep       Date:  2011-02       Impact factor: 4.810

Review 4.  Sleep and pregnancy-induced hypertension: a possible target for intervention?

Authors:  Alyssa Haney; Daniel J Buysse; Michele Okun
Journal:  J Clin Sleep Med       Date:  2013-12-15       Impact factor: 4.062

5.  Ambulatory screening for obstructive sleep apnea in patients with resistant arterial hypertension.

Authors:  Monika Kamasová; Jan Václavík; Tomáš Václavík; Milada Hobzová; Eva Kociánová; Miloš Táborský
Journal:  Sleep Breath       Date:  2017-10-27       Impact factor: 2.816

6.  Mitochondrial DNA Copy Number in Sleep Duration Discordant Monozygotic Twins.

Authors:  Joanna E Wrede; Jonas Mengel-From; Dedra Buchwald; Michael V Vitiello; Michael Bamshad; Carolyn Noonan; Lene Christiansen; Kaare Christensen; Nathaniel F Watson
Journal:  Sleep       Date:  2015-10-01       Impact factor: 5.849

7.  Effects of Two-Week Sleep Extension on Glucose Metabolism in Chronically Sleep-Deprived Individuals.

Authors:  Apichart So-Ngern; Naricha Chirakalwasan; Sunee Saetung; Suwannee Chanprasertyothin; Ammarin Thakkinstian; Sirimon Reutrakul
Journal:  J Clin Sleep Med       Date:  2019-05-15       Impact factor: 4.062

Review 8.  Obstructive sleep apnea, hypertension and cardiovascular diseases.

Authors:  C Gonzaga; A Bertolami; M Bertolami; C Amodeo; D Calhoun
Journal:  J Hum Hypertens       Date:  2015-03-12       Impact factor: 3.012

Review 9.  Neurogenic hypertension and the secrets of respiration.

Authors:  Benedito H Machado; Daniel B Zoccal; Davi J A Moraes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-24       Impact factor: 3.619

10.  Management of Resistant Hypertension: Do Not Give Up on Medication.

Authors:  Eric Judd; David A Calhoun
Journal:  Nephrol Self Assess Program       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.